---
title: "A second surgical platform makes the business case harder"
description: "Evaluate a surgical device through clinical need, service capacity and a costed pilot before making it part of India's aesthetic medical travel offer."
date: "2026-08-26"
updated: "2026-09-16"
topic: "Operations automation"
canonical_url: "https://rolstonpaul.com/writing/second-robot-harder-business-case"
author: "Rolston Paul"
reading_time: "4 min read"
---

# A second surgical platform makes the business case harder

Evaluate a surgical device through clinical need, service capacity and a costed pilot before making it part of India's aesthetic medical travel offer.

A second surgical platform should make an Operations Head ask better questions, not buy sooner. I would start with the constraint the service needs to solve. Then I would look at the clinical evidence needed and the cost of keeping the equipment useful. In an Indian aesthetic medical tourism programme, a device earns its place when it supports a suitable service that the team can deliver. Its presence alone is not evidence of a better result. This matters because an international patient books care, not a machine. If the equipment is idle, unsupported or run by an untrained team, the patient carries that risk far from home. For the operator, a device the service cannot keep running turns a marketing claim into a broken promise.

## Name the constraint before the demonstration

Write the problem in a sentence. It may be a performance measure set in clinical terms. It may be whether a trained team is free, the schedule, or an unreliable service arrangement. If the problem is unclear, an impressive demo can become the answer to a question the clinic never needed to ask.

The clinical lead should assess the planned use and the evidence for it. My role is to set the operating baseline and the resources needed to test the claim. I would not turn a vendor's throughput figure straight into a promise to patients from abroad.

## Use the full-cost test

The full-cost test covers purchase or lease payments, upkeep, consumables, training, downtime and any facilities work. It also records the assumptions about actual use. I would model more than one level of demand. The investment should not depend on a diary that is always full.

Ask what happens when the equipment cannot be used. Where is service support based? What does the contract commit to? Is there a replacement, or another clinical arrangement? Record the answer in the same model as the price.

> A purchase decision includes the days when the equipment cannot be used.

## Verify permission and capability

Before I approve a pilot, I would get a current review of the device's regulatory position. It should cover the intended market and use. Do not treat a certificate from another jurisdiction as a full answer. The specialists in charge need to check the rules that apply.

Training records also need a clinical owner. Going to a vendor session is not, on its own, an assessment of whether someone is ready to do clinical work. The operating plan should state who is authorised for each task. It should say how competence is assessed and how supervision will work.

## Define the comparison before starting

A pilot needs a baseline, a defined patient group and clinical measures selected by qualified reviewers. State how cases will be chosen and how missing follow-up will be handled. The business case should include the real extra work the pilot needs.

Some aesthetic patients come from overseas for care in India. For them, I would also test whether the planned workflow changes records, recovery plans or support after they leave. A faster step inside the clinic does not always cut the work needed elsewhere. The comparison should follow the whole service on offer.

## Decide what survives the equipment

The operating edge I would seek for India is a team that can judge new technology. That team does not let marketing outrun clinical evidence. It gives an honest account of what the device does. It uses a proper selection process and has a clear response when the plan changes.

A successful pilot can support a purchase. An unsuccessful one can justify stopping. Both results are useful if the decision rules were written first. That means before anyone grew attached to the announcement. An Operations Head should make room for either outcome.

A vendor's next release and a competitor's purchase are not reasons to buy a second robot. The baseline, the assumptions in the cost model and the service's readiness to support the equipment are. I would settle those before I make the investment.

## Questions people ask

### How should a clinic evaluate a surgical device purchase?

Define the clinical or operational problem first, then assess the evidence, permissions, team capability and full cost of use. A pilot should have a baseline and decision criteria agreed in advance. The clinical lead owns clinical evaluation; operations should establish the staffing, service arrangements and financial assumptions required for a sustainable service.

### What belongs in the cost of surgical equipment?

Include purchase or lease costs, maintenance, consumables, training, facilities changes and the consequences of downtime. Model the level of use the service can realistically support. Check the actual support contract and contingency arrangements. A lower acquisition price does not settle the investment if essential service capacity has been omitted from the calculation.

### Does new technology establish leadership in aesthetic medical tourism?

A device alone does not establish a provider's quality or guarantee a patient's result. I would assess leadership through the service around it: appropriate clinical evaluation, assessed team capability, honest communication and dependable follow-up. India's opportunity is to demonstrate those operating standards while evaluating technology on evidence rather than novelty.

---

Canonical page: https://rolstonpaul.com/writing/second-robot-harder-business-case
Topic guide: https://rolstonpaul.com/topics/operations-automation
Published 26 August 2026 by Rolston Paul. Contact: info@rolstonpaul.com
